Therefore, the purpose of the present study was initially to explore the role and value of NSE in predicting prognosis in advanced and metastatic non-neuroendocrine NSCLC patients (SCC and adenocarcinoma). The gene discussed is ENO2; the disease is adenocarcinoma.